Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lesley C Dupuy

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Opinion in Virology|June 20, 2012
Nonhuman primate models of encephalitic alphavirus infection: historical review and future perspectivesLesley C Dupuy, Douglas S Reed
Expert Review of Vaccines|December 1, 2009
DNA vaccines for biodefenseLesley C Dupuy, Connie S Schmaljohn
Vaccine|May 22, 2016
A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporationDrew Hannaman, Lesley C Dupuy, Barry Ellefsen, et al.
Vaccine|September 21, 2010
Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primatesLesley C Dupuy, Michelle J Richards, Douglas S Reed, et al.
Journal of Immunology Research|July 4, 2018
A Multiagent Alphavirus DNA Vaccine Delivered by Intramuscular Electroporation Elicits Robust and Durable Virus-Specific Immune Responses in Mice and Rabbits and Completely Protects Mice against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol ChallengesLesley C Dupuy, Michelle J Richards, Brian D Livingston, et al.
Journal of Virology|July 30, 2003
Probing the importance of tRNA anticodon: human immunodeficiency virus type 1 (HIV-1) RNA genome complementarity with an HIV-1 that selects tRNA(Glu) for replicationLesley C Dupuy, Nathan J Kelly, Tricia E Elgavish, et al.
Comparative Medicine|October 5, 2018
Comparison of Aerosol- and Percutaneous-acquired Venezuelan Equine Encephalitis in Humans and Nonhuman Primates for Suitability in Predicting Clinical Efficacy under the Animal RuleJanice M Rusnak, Lesley C Dupuy, Nancy A Niemuth, et al.
Human Vaccines & Immunotherapeutics|September 19, 2017
Combinatorial peptide-based epitope mapping from Ebola virus DNA vaccines and infections reveals residue-level determinants of antibody bindingDaniel R Ripoll, Daniel A J Mitchell, Lesley C Dupuy, et al.
The Journal of Infectious Diseases|October 18, 2023
Filoviruses: Scientific Gaps and Prototype Pathogen RecommendationLesley C Dupuy, Christina F Spiropoulou, Jonathan S Towner, et al.
The Journal of Infectious Diseases|July 28, 2018
The Genetic Adjuvants Interleukin-12 and Granulocyte-Macrophage Colony Stimulating Factor Enhance the Immunogenicity of an Ebola Virus Deoxyribonucleic Acid Vaccine in MiceJohn J Suschak, Kenneth Bagley, Charles J Shoemaker, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Opinion in Virology|June 20, 2012
Nonhuman primate models of encephalitic alphavirus infection: historical review and future perspectivesLesley C Dupuy, Douglas S Reed
Expert Review of Vaccines|December 1, 2009
DNA vaccines for biodefenseLesley C Dupuy, Connie S Schmaljohn
Vaccine|May 22, 2016
A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporationDrew Hannaman, Lesley C Dupuy, Barry Ellefsen, et al.
Vaccine|September 21, 2010
Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primatesLesley C Dupuy, Michelle J Richards, Douglas S Reed, et al.
Journal of Immunology Research|July 4, 2018
A Multiagent Alphavirus DNA Vaccine Delivered by Intramuscular Electroporation Elicits Robust and Durable Virus-Specific Immune Responses in Mice and Rabbits and Completely Protects Mice against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol ChallengesLesley C Dupuy, Michelle J Richards, Brian D Livingston, et al.
Journal of Virology|July 30, 2003
Probing the importance of tRNA anticodon: human immunodeficiency virus type 1 (HIV-1) RNA genome complementarity with an HIV-1 that selects tRNA(Glu) for replicationLesley C Dupuy, Nathan J Kelly, Tricia E Elgavish, et al.
Comparative Medicine|October 5, 2018
Comparison of Aerosol- and Percutaneous-acquired Venezuelan Equine Encephalitis in Humans and Nonhuman Primates for Suitability in Predicting Clinical Efficacy under the Animal RuleJanice M Rusnak, Lesley C Dupuy, Nancy A Niemuth, et al.
Human Vaccines & Immunotherapeutics|September 19, 2017
Combinatorial peptide-based epitope mapping from Ebola virus DNA vaccines and infections reveals residue-level determinants of antibody bindingDaniel R Ripoll, Daniel A J Mitchell, Lesley C Dupuy, et al.
The Journal of Infectious Diseases|October 18, 2023
Filoviruses: Scientific Gaps and Prototype Pathogen RecommendationLesley C Dupuy, Christina F Spiropoulou, Jonathan S Towner, et al.
The Journal of Infectious Diseases|July 28, 2018
The Genetic Adjuvants Interleukin-12 and Granulocyte-Macrophage Colony Stimulating Factor Enhance the Immunogenicity of an Ebola Virus Deoxyribonucleic Acid Vaccine in MiceJohn J Suschak, Kenneth Bagley, Charles J Shoemaker, et al.
Pageof 3